Darifenacin Tablet, Extended Release
Product Images NDC 69097-431

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Darifenacin (NDC 69097-431). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ac7bdb75 9e1e 4255 9766 D1e85dd97d14 01

FDA Label Image

Ac7bdb75 9e1e 4255 9766 D1e85dd97d14 02

FDA Label Image

Ac7bdb75 9e1e 4255 9766 D1e85dd97d14 03

FDA Label Image

Ac7bdb75 9e1e 4255 9766 D1e85dd97d14 04

FDA Label Image

Ac7bdb75 9e1e 4255 9766 D1e85dd97d14 05

FDA Label Image

Ac7bdb75 9e1e 4255 9766 D1e85dd97d14 06

Ac7bdb75 9e1e 4255 9766 D1e85dd97d14 06
This is a prescription-only medication with the NDC code 69097-431-02. Each extended-release tablet contains 8.929 mg of darifenacin E hydrobromide, providing 7.5 mg of darifenacin. The medication is meant for oral consumption and should be kept out of the reach of children. The tablets need to be stored at a temperature of 25°C (77°F), with excursions between 15°C to 30°C (59°F to 86°F) permitted. The manufacturer is Cipla Ltd. and the medication is sold in a pack of 30 tablets. Expiry and batch information are overprinted during commercial packing.*
FDA Label Image

Ac7bdb75 9e1e 4255 9766 D1e85dd97d14 07

Ac7bdb75 9e1e 4255 9766 D1e85dd97d14 07
This is a description of a medication with the NDC number 69097-432-02, which is a prescription-only medication. Each tablet is a film-coated extended-release tablet containing 17.858 mg of darifenacin hydrobromide to provide 15 mg darifenacin. The recommended adult dosage is one tablet per day. The tablets should be kept out of the reach of children, stored at 25°C (77°F) with excursions allowed between 15°C to 30°C (59°F to 86°F), and protected from light. The manufacturer is Clpla Ltd. in India, and the medication is manufactured for Clpla USA, Inc. There are 30 tablets per bottle. Information on the batch number, serial number, expiry, and lot will be overprinted during commercial packing.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.